University of South Florida Awarded $128 Million Type 1 Diabetes Grant
The University of South Florida (USF) has been awarded a $128 million, 7-year grant from the National Institutes of Health (NIH) to coordinate worldwide studies on the prevention and treatment of Type 1 diabetes. Diabetes researcher Dr. Jeffrey Krischer will head the study's data coordinating and technology center. The new funding goes toward a study called TrialNET, in which researchers will screen more than 150,000 children and adults for early signs of diabetes. Those considered at high risk may receive novel drugs to prevent progression of the disease. Dr. Krischer also chairs one of the studies in TrialNET, an investigation into the preventative role of insulin in individuals who are genetically predisposed to develop Type 1 diabetes.
In 2007, Dr. Krischer received funding for The Environmental Determinants of Diabetes in the Young (TEDDY) - a $169-million, 10-year grant awarded by the NIH. Over 250,000 newborns in six countries will be screened by TEDDY to locate newborns that are genetically at high risk to develop Type 1 diabetes. Researchers will subsequently study approximately 8,000 identified at-risk infants for 15 years in an effort to determine whether food, illnesses or other factors influence who among them develops diabetes. As is the case with the most recent award, the funds are being used in studies that move from identification of the genesis of the disease toward prevention and treatment.
Dr. Krisher has been awarded a …